Boudewijn van Etten Selected Research

Neoplasms (Cancer)

7/2021	Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis.
1/2020	Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer.
1/2020	A Systematic Review and Meta-analysis on Omentoplasty for the Management of Abdominoperineal Defects in Patients Treated for Cancer.
8/2018	False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors.
3/2013	Surgical management of rectal gastrointestinal stromal tumors.
4/2005	Gene therapy in in vivo isolated perfusion models.
1/2003	Fifty tumor necrosis factor-based isolated limb perfusions for limb salvage in patients older than 75 years with limb-threatening soft tissue sarcomas and other extremity tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boudewijn van Etten Research Topics

Disease

16	Rectal Neoplasms (Rectal Cancer) 04/2024 - 06/2013
7	Neoplasms (Cancer) 07/2021 - 01/2003
6	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2004
5	Stomach Neoplasms (Stomach Cancer) 03/2024 - 06/2013
4	Wounds and Injuries (Trauma) 01/2022 - 08/2014
2	Hernia (Hernias) 01/2022 - 08/2014
2	Adenocarcinoma 01/2021 - 09/2018
2	Melanoma (Melanoma, Malignant) 08/2005 - 01/2003
1	Anastomotic Leak 11/2023
1	Esophageal Neoplasms (Esophageal Cancer) 07/2021
1	Infections 01/2020
1	Rupture 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 08/2018
1	Pathologic Complete Response 02/2018
1	Carcinoma (Carcinomatosis) 02/2018
1	Delirium 01/2017
1	Postoperative Pain 01/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017
1	Emergence Delirium 01/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Hypersensitivity (Allergy) 08/2014
1	Colorectal Neoplasms (Colorectal Cancer) 06/2013
1	Colonic Neoplasms (Colon Cancer) 06/2013
1	Sarcoma (Soft Tissue Sarcoma) 01/2003

Drug/Important Bio-Agent (IBA)

3	BiopexIBA 01/2022 - 08/2014
2	PlasticsIBA 03/2024 - 12/2021
2	Trinitrotoluene (TNT)IBA 10/2023 - 01/2022
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 03/2013
2	Capecitabine (Xeloda)FDA Link 01/2020 - 09/2018
2	Melphalan (Alkeran)FDA LinkGeneric 08/2005 - 01/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005 - 01/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 09/2018
1	Docetaxel (Taxotere)FDA Link 09/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2018
1	Levodopa (L Dopa)FDA LinkGeneric 08/2018
1	fluorodopa F 18IBA 08/2018
1	C-Reactive ProteinIBA 01/2017
1	Polysorbates (PSML)FDA Link 08/2014
1	CollagenIBA 08/2014
1	indolepropanol phosphate (IPP)IBA 04/2005

Therapy/Procedure

11	Radiotherapy 04/2024 - 06/2013
10	Chemoradiotherapy 04/2024 - 06/2013
7	Neoadjuvant Therapy 04/2024 - 02/2018
6	Drug Therapy (Chemotherapy) 01/2023 - 05/2008
5	Proctectomy 01/2022 - 08/2014
3	Therapeutics 11/2023 - 01/2021
3	Adjuvant Chemotherapy 01/2021 - 06/2013
2	Gastrectomy 03/2024 - 11/2023
2	Length of Stay 01/2017 - 08/2014
1	Gastroenterostomy 11/2023
1	Re-Irradiation 09/2021
1	Brachytherapy 01/2021
1	Adjuvant Chemoradiotherapy 09/2018
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Adjuvant Radiotherapy 08/2014
1	Catheters 06/2004
1	Limb Salvage 01/2003
1	Surgical Amputation (Amputations) 01/2003